Biotech

All Articles

Novo inks $600M NanoVation offer to examine hereditary medications ex-liver

.Novo Nordisk is actually continuing its own push into hereditary medications, agreeing to pay NanoV...

Innovent links cytokine to intestines cancer cells responses

.Innovent Biologics has actually produced the scenario that its own checkpoint inhibitor-cytokine bl...

Merck, Daiichi ADC strikes goal in stage 3 lung cancer cells research

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina strengthens AI center along with collab to choose cancer targets

.Five months after Rakovina Therapeutics pivoted towards artificial intelligence, the cancer-focused...

Ascendis' dwarfism medication favorites in period 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, disclosing phase 3 growth ...

Despite ph. 3 miss out on, Alkeus sees course ahead of time for eye disease possession

.Though Alkeus Pharmaceuticals' oral eye condition property fell short to significantly lessen geogr...

Kairos goes social along with $6M IPO to fund tests of cancer drug

.With a triad of biotechs reaching the Nasdaq on Friday, it was actually simple to miss a smaller-sc...

Vaccine and also Keytruda combo successful in squamous tissue carcinoma

.Invulnerable gate inhibitors are the superheroes of cancer cells treatment. Medications like Bristo...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial management hirings, firings and a...

Regeneron's Opdualag rival reveals 57% feedback cost

.Regeneron is back along with lasting follow-up for its LAG-3 inhibitor and PD-1 inhibitor combinati...